Trial Site Detail

 

Drug:
MEK162 + BYL719
Trial:
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Moores Cancer Center/UCSD Medical center

     
La Jolla , CA 92093
USA

 

Principal Investigator:
 Steven Plaxe
Contact:
 Elisa Arthur 858-822-5367 eparthur@ucsd.edu
Activation Status of this Site:
 Closed
Notes about this Site:
Moores Cancer Center/UCSD Medical center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.